Conference abstractPublished 25 Aug 2015
Innovative test to predict drug-induced neurotoxicity and psychiatric side effects
Alcediag, France
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Severe drug-induced psychiatric side effects as depression and suicide recently resulted in market withdrawal of compounds like Rimonabant, emission of FDA alerts (Champix, Roaccutane) or law suites (Paxil). Current non clinical safety studies, whether safety pharmacology or toxicity studies cannot detect these severe side effects leading to dramatic human deaths and expensive late withdrawals. RNA editing of the serotonin 2C receptor (5-HT2cR) has been shown to be altered in postmortem brains of depressed patients and suicide committers. Alcediag has characterized a specific RNA editing signature of the 5-HT2cR linked to depressed/suicide patients. By using next generation sequencing technology (Illumina), Alcediag determined the editing profiles of the serotonin 2C receptor in SH-SY5Y human neuroblastoma cell line, treated with 54 marketapproved drugs at 3 concentrations. These compounds were selected from various therapeutic classes (antidepressant, antipsychotic, anti-obesity, antiviral, anti-inflammatory, anti-fungic, antiepileptic, mood stabilizing agents and others) as potentially inducing suicidality (FDA warning label) or not (no psychiatric side effects reported). The screening could identify a specific ‘at risk signature’, similar to that found in post mortem brain of suicide patients. Clear dose-effect relationships were observed. An algorithm was generated to identify ’at risk’ compounds with 80% sensitivity and 90% specificity. This test is the first in vitro test able to characterize a potential pharmacotoxicity on the brain. Based on the same approach, a blood test was developped to assess the suicide risk in patients. First data exhibit high sensitivity and specificity. Taken together, those tests open new perspectives in personalized medicine in psychiatry.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectMental Health and Psychology
- SubjectNeuroscience & Neurology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “D. Weissmann”